BUSINESS● LOWJul 22 · Jul 22, 2026, 6:45 AM
Dyne Therapeutics stock slips after pricing upsized $375M public offering at $20.50 per share
Seeking Alpha Tech
No summary available — read the full story at the source.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Business
BUSINESSnowMunicipal Securities Underwriters Pay a Total of $325,000 in FinesSECBUSINESSnowSEC CHAIRMAN ARTHUR LEVITT, IOWA OFFICIALS TO HOLD INVESTORS’ TOWN MEETING IN DES MOINESSECBUSINESSnowFacing Ethiopian Airlines, the perilous recovery of Kenya Airways and South African AirwaysJeune AfriqueBUSINESS33m agoOyedele links N30tn monetary financing to Nigeria’s inflation pressuresPremium Times